Mapping large numbers of results may take a few moments.
|Company Kowa Research Institute Inc.||Activity: Research and Development||Company Description Kowa Research Institute, a division of Kowa Company Ltd., develops therapeutic drugs for the treatment of cardio-metabolic diseases such as diabetes and atherosclerosis, pain and sensory organ disorders.||Location Morrisville|
|Company Micell Technologies Inc.||Activity: Research and Development||Company Description Micell Technologies develops combination-product therapies for interventional cardiology. Micell markets MiStent, a drug-eluting stent, in Europe and certain other regions.||Location Durham|
|Company NuPulseCV||Activity: Research and Development||Company Description NuPulseCV is developing an implantable cardiovascular left ventricular assist device to treat people suffering from congestive heart failure.||Location Raleigh|
|Company Veloxis Pharmaceuticals Inc.||Activity: Sales and Operations||Company Description Veloxis Pharmaceuticals is focused on the commercialization of ENVARSUS XR (tacrolimus extended-release tablets) based upon the company’s patented delivery technology, MeltDose.||Location Cary|